Source: Fortune
A clinical trial failure and U. S. competition have been tough for the Danish pharmaceutical firm.
Aller á la Source
Nouvelles connexes
List des news
Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult
Weight
Fortune
ha 9h
